Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening
Abstract Background Current guidelines for mammography screening for breast cancer vary across agencies, especially for women aged 40–49. Using artificial Intelligence (AI) to read mammography images has been shown to predict breast cancer risk with higher accuracy than alternative approaches includ...
Main Authors: | Shweta Mital, Hai V. Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-09613-1 |
Similar Items
-
Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysisResearch in context
by: Changfa Xia, et al.
Published: (2024-03-01) -
A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score
by: Zixuan Zhao, et al.
Published: (2024-01-01) -
Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore
by: Jerry Zeng Yang Wong, et al.
Published: (2021-04-01) -
Polygenic risk scores and breast cancer risk prediction
by: Eleanor Roberts, et al.
Published: (2023-02-01) -
Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
by: Xiaopu Zhou, et al.
Published: (2021-03-01)